AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06010537 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: polysaccharide superparamagnetic iron oxide injection
Description: Polysaccharide superparamagnetic iron oxide injection is a magnetic resonance contrast agent.
Study NCT06434090 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal irinotecan
Description: Liposomal irinotecan will be given biweekly at a dose from 70mg/m2 to 90mg/m2.
Study NCT06434090 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: bevacizumab will be given biweekly at a dose of 5mg/m2
Study NCT05343845 — intervention group
Intervention type: OTHER
Intervention: Observational study
Description: After approval of the institution's ethics committee, 100 patients will be divided in two groups as pregnant women who did not smoke during pregnancy and pregnant women who smoked 5 or more cigarettes in a day. The local anesthetic, which dose will adjusted according to height and weight, and 20 µg fentanyl will be administered intrathecally to both groups. Results on the effectiveness of spinal anesthesia will be monitored.
Study NCT05255705 — intervention group
Intervention type: OTHER
Intervention: Observation only
Description: Observation only
Study NCT06111807 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA
Description: ctDNA will be tested retrospectively, no treatment decisions will be made prospectively
Study NCT05182905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD1390
Description: Phase 0: AZD1390 administered orally daily for 3 days prior to resection~Phase 1b: AZD1390 administered daily for 5 days concurrently with standard of care radiation therapy
Study NCT04790422 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary fiber supplement
Description: Dietary fiber
Study NCT04790422 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Caseine protein hydrolisate
Description: Dietary supplement
Study NCT04790422 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltrodextrine
Description: Placebo comparator
Study NCT06557447 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Immunological and microbiological sample of peri-implant crevicular fluid; clinical evaluation
Description: Immunological sample collection involves placing a Periopaper strip in the peri-implantar sulcus for 30 seconds. If sample is contaminated with blood, sample will be discarded and another sample will be collected (a different surface of the same implant/tooth can be used).~Microbiological sample collection involves collecting subgingival dental plaque by sliding the end of the STERILE curette (Gracey) inside the peri-implant sulcus. In case of slight bleeding following the first sample, dry the site again before collection. In case of profuse bleeding, collect a sample from another site (by site mean mesial/buccal/distal/lingual) of the same implant.~Both immunological and microbiological samples will be sent for respective laboratories for the analysis.~Clinical evaluation will assess presence of dental plaque, bleeding on probing and gingival status.
Study NCT05122832 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: Glucose Glycosylated hemoglobin Triglycerides Total cholesterol HDL Cholesterol LDL Cholesterol Creatinine COVID-19 Antibody IgM to N protein SARS-Cov-2 (Abbott) COVID-19 Antibody IgG to N protein SARS-Cov-2 (Abbott)
Study NCT05122832 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: STEPwise Approach to NCD Risk Factor Surveillance (STEPS)
Description: The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids. Through the use of expanded modules, the survey instrument can be expanded to cover a range of topics beyond these risk factors, such as oral health, sexual health and road safety.
Study NCT05122832 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spirometry
Description: Spirometry is a common office test used to assess how well your lungs work by measuring how much air you inhale, how much you exhale and how quickly you exhale.
Study NCT05501301 — intervention group
Intervention type: OTHER
Intervention: IS weaning off
Description: IS weaning off will be conducted in recipients with chronic virus infection or side effects of IS
Study NCT06419595 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Behavioral: Screening and Support for Youth (SASY) Multi-component Platform: includes screening, feedback, single session intervention, and resource information
Description: Description: Description: Participants who interact with a QR code and express interest in participating will be randomized to receive either: 1) recruitment from a Research Coordinator (standard research staff approach) or 2) recruitment from an EYE for Prevention Youth Researcher. The process of consent, screening, providing feedback, and offering access to a Single Session Intervention and information on additional resources (per scoring on the screening into Tier 1 (low risk/normal), 2 (moderate/at risk), or 3 (high/clinical risk): Tier 1 = screening+feedback; Tier 2=screening+feedback+SSI; Tier 3=screening+feedback+SSI+resource information) will be the same in each group. The randomization is simply changing who provides the process and platform to the participant.
Study NCT04485468 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: The patient answers the questionnaire directly following his consultation or teleconsultation or may arrange a telephone appointment with the clinical research associate a little later.
Study NCT05319223 — intervention group
Intervention type: BEHAVIORAL
Intervention: patient blood management
Description: three pillars of patient blood management will be applied
Study NCT05326568 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Complementary treatment practice
Description: Applying sesame oil to the patients assigned to the intervention group by applying 10 drops to the 10 cm circumference of the cannula for 10 minutes
Study NCT04904341 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cerebrolysin
Description: neuroprotection treatment
Study NCT05185219 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Valerian
Description: A natural plant
Study NCT05185219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valerian
Description: A natural plant
Study NCT05795868 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Compression stocks
Description: Pregnant women in the compression stockings group will wear the socks given for 3 weeks.
Study NCT05795868 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Knee socks
Description: Pregnant women in the Knee socks group will wear the socks given for 3 weeks.
Study NCT05308082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance Movement Therapy (DMT)
Description: The main Dance Movement Therapy (DMT) methods were dance-movement improvisations, body awareness exercises, and reflection through drawing/painting, writing, and verbalization. There was an orientation to personal space and body awareness, interaction in pairs, and interaction in the whole group. The themes included exploration of boundaries, somatic resources, symbols, pleasant and unpleasant emotions, mindfulness, and body awareness, enriched movement experiences, and safety and touch. In the present study, it consists of six sessions, including (1) Movement for Self-expression, (2) Movement for Emotional Health I, (3) Movement for Emotional Health II, (4) Movement for Connection \& Creativity, (5) Embracing your Dancing Child, and (6) Movement for Self-compassion.
Study NCT05342142 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic and ResistanceExercise
Description: Exercise program consisting of 12 weeks of aerobic and resistance exercises
Study NCT05180084 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Description: Internet-based CBT intervention based on CBT theory, self-determination theory and self-compassion therapy for low self-esteem among young adults.
Study NCT04620928 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Concepts
Description: Images and sounds that are characteristic of various common objects.
Study NCT06236763 — intervention group
Intervention type: DEVICE
Intervention: TOFscan foot
Description: TOFscan will be applied on the foot and recovery from neuromuscular blockade will be observed over time. These will be compared with the control (TOFscan at the hand) on the same patient (gold standard monitor).
Study NCT05847582 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard inpatient psychiatric care
Description: All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.
Study NCT04749160 — intervention group
Intervention type: DEVICE
Intervention: Connected device
Description: Connected device is a smart watch (with accelerometer without location data).
Study NCT05847582 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard inpatient psychiatric care
Description: All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.
Study NCT05847582 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Inpatient Skills Training
Description: Inpatient skills training will be completed while participants are receiving inpatient treatment at BHIP. Skills training includes content designed to improve emotional regulation skills.
Study NCT05847582 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inpatient Skills Training
Description: Inpatient skills training will be completed while participants are receiving inpatient treatment at BHIP. Skills training includes content designed to improve emotional regulation skills.
Study NCT05847582 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth-supported Skills Training for Alcohol-Related Suicidality (mSTARS)
Description: mSTARS includes inpatient skills training and a mobile health (mHealth) telephone app designed to encourage participants to apply skills acquired in inpatient skills training to real-life situations.
Study NCT04783766 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CK-3773274
Description: CK-3773274- Tablets
Study NCT04783766 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo- Tablets
Study NCT04734080 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dronabinol 5mg Cap
Description: Dronabinol is a synthetic tetrahydrocannabinol (THC) agent approved for nausea and vomiting with chemotherapy and as an appetite stimulant in AIDS patients.
Study NCT04734080 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Non-active placebo
Study NCT06451627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: Esketamine ( 50mg, dissolved in 50ml normal saline ) will be infused at a speed of 0.3mg / kg / h during surgery .
Study NCT06451627 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: saline
Description: Saline will be infused at a speed of 0.3mg / kg / h during surgery .
Study NCT05147116 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sleeping in a tent
Description: Participants will spend 10 consecutive nights of sleeping in a tent
Study NCT05147116 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sleeping in a tent
Description: Participants will spend 10 consecutive nights of sleeping in a tent
Study NCT06646042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ibuzatrelvir
Description: 2x 300 mg tablet
Study NCT06646042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carbamazepine ER
Description: 100 mg BID (Day 1-3) 200 mg BID (Day 4-7) 300 mg BID (Day 8-15)
Study NCT06559150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nebulized Ensifentrine Suspension; 3 mg
Description: Administered by a standard jet nebulizer, twice daily for a minimum of 24 weeks and up to a maximum of 156 weeks (3 years)
Study NCT06559150 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nebulized Placebo Solution
Description: Administered by a standard jet nebulizer, twice daily for a minimum of 24 weeks and up to a maximum of 156 weeks (3 years)
Study NCT06285448 — intervention group
Intervention type: DRUG
Intervention: Lecanemab
Description: Bi-weekly infusions of lecanemab \[exposure\].
Study NCT05810298 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Asana Practice
Description: Yogasana training will be comprised of active movements when standing. Spine and limbs stretches eccentrically respecting the movement patterns of body without pushing limits. Transition in between poses will be synchronized with breathing pattern in zero resistance flow. The exercises will be done 2 days a week online under the supervision of physiotherapist. Total duration of standing poses training will last for 4 weeks.
Study NCT05810298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Asana Practice
Description: Yogasana training will be comprised of active movements when standing. Spine and limbs stretches eccentrically respecting the movement patterns of body without pushing limits. Transition in between poses will be synchronized with breathing pattern in zero resistance flow. The exercises will be done 2 days a week online under the supervision of physiotherapist. Total duration of standing poses training will last for 4 weeks.
Study NCT05810298 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pranayam Practice (Rhythmic regulated breathing)
Description: Breathing exercises will be comprised of diaphragmatic breathing, holding the breath after inhaling deeply and exhaling passively or exhaling actively by contracting abdominal muscles and inhaling passively. The exercises will be done 2 days a week online under the supervision of physiotherapist. Total duration of breathing exercises will last for 4 weeks.
Study NCT05810298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pranayam Practice (Rhythmic regulated breathing)
Description: Breathing exercises will be comprised of diaphragmatic breathing, holding the breath after inhaling deeply and exhaling passively or exhaling actively by contracting abdominal muscles and inhaling passively. The exercises will be done 2 days a week online under the supervision of physiotherapist. Total duration of breathing exercises will last for 4 weeks.
Study NCT05810298 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking Education Program
Description: The aim of the education is to increase awareness of subjects who are chronical smokers. The subject education will be performed at least once via face to face interview. Education topics will be covered basic information about harmful effects of habitual smoking and how to reduce the side effects of nicotine withdrawal.
Study NCT05374291 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day (oral)
Description: Patients take 10 mg dapagliflozin or matching placebo once daily in the morning
Study NCT05374291 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients take 10 mg dapagliflozin or matching placebo once daily in the morning
Study NCT06153095 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IMPT-514
Description: CAR T-cell therapy administered intravenously after a lymphodepleting therapy regimen consisting of fludarabine and cyclophosphamide
Study NCT05455307 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Allium ureteral stent
Description: observe the effficacy and safety of long-term self expanding ureteral stents for treating refractory ureteral stricture
Study NCT05579223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intrathecal Hydromorphone Mono Injection
Description: Experimental Drug: Hydromorphone Hydrochloride Injection. Administration: subarachnoid space mono bolus inject, + 5% glucose injection diluted to 75 μg:1.5ml, Speed ≤ 0.5 ml/s
Study NCT05579223 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Intrathecal Placebo Mono Injection
Description: Placebo: 5% glucose injection. Administration: subarachnoid space mono bolus inject, 1.5ml, Speed ≤ 0.5 ml/s
Study NCT05001568 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate in-brace correction: Conventional Brace
Description: The trunk surface will be scanned to reconstruct a numerical model of the patient's trunk, this reconstruction will help to produce the optimized brace. The patient skeletal will also be reconstructed from a bilateral radiograph using an EOS imaging system. Each patient will try both the control and the test brace. Radiographic (supine position) and patient-reported data will be gathered and analyzed to observe changes between the immediate correction of the braces. The SRS-22r will be collected. The study protocol requires no additional visits beyond the standard of care. There will be one additional radiograph compared to the standard of care.
Study NCT05001568 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Immediate in-brace correction: Conventional Brace
Description: The trunk surface will be scanned to reconstruct a numerical model of the patient's trunk, this reconstruction will help to produce the optimized brace. The patient skeletal will also be reconstructed from a bilateral radiograph using an EOS imaging system. Each patient will try both the control and the test brace. Radiographic (supine position) and patient-reported data will be gathered and analyzed to observe changes between the immediate correction of the braces. The SRS-22r will be collected. The study protocol requires no additional visits beyond the standard of care. There will be one additional radiograph compared to the standard of care.
Study NCT05001568 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate in-brace correction: Optimized Brace
Description: The trunk surface will be scanned to reconstruct a numerical model of the patient's trunk, this reconstruction will help to produce the optimized brace. The patient skeletal will also be reconstructed from a bilateral radiograph using an EOS imaging system. Each patient will try both the control and the test brace. Radiographic (supine position) and patient-reported data will be gathered and analyzed to observe changes between the immediate correction of the braces. The SRS-22r will be collected. The study protocol requires no additional visits beyond the standard of care. There will be one additional radiograph compared to the standard of care.
Study NCT05001568 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Immediate in-brace correction: Optimized Brace
Description: The trunk surface will be scanned to reconstruct a numerical model of the patient's trunk, this reconstruction will help to produce the optimized brace. The patient skeletal will also be reconstructed from a bilateral radiograph using an EOS imaging system. Each patient will try both the control and the test brace. Radiographic (supine position) and patient-reported data will be gathered and analyzed to observe changes between the immediate correction of the braces. The SRS-22r will be collected. The study protocol requires no additional visits beyond the standard of care. There will be one additional radiograph compared to the standard of care.
Study NCT05001568 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Long-term bracing: Conventional Brace
Description: After comparing the immediate correction of the braces, each patient will be using either the test or the control brace for a period of two years. There will be follow-up visits, between 6 months and 1 year depending on the patient growth. The brace will be renewed using the same procedure to adapt to the patient's growth. The study protocol requires no additional visits beyond the standard of care. There will be no additional radiograph compared to the standard of care. Compliance monitors are installed in each brace.
Study NCT05001568 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Long-term bracing: Optimized Brace
Description: After comparing the immediate correction of the braces, each patient will be using either the test or the control brace for a period of two years. There will be follow-up visits, between 6 months and 1 year depending on the patient growth. The brace will be renewed using the same procedure to adapt to the patient's growth. The study protocol requires no additional visits beyond the standard of care. There will be no additional radiograph compared to the standard of care. Compliance monitors are installed in each brace.
Study NCT05921357 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire and examine
Study NCT06400134 — intervention group
Intervention type: OTHER
Intervention: Cognitive Function
Description: The Standardized Mini Mental Test (SMMT) was used to evaluate the cognitive status of the geriatric individuals'. In the test, which has a total score of 30, those with a score of 24 or less are recommended to be evaluated for dementia.
Study NCT06400134 — intervention group
Intervention type: OTHER
Intervention: Physical Performance
Description: The Brief Physical Performance Battery (BPPB) was used to assess the physical performance of geriatric individuals. All three physical performance measures (balance, walking speed, getting up from the chair) were scored between 0-4 according to the duration of the activity, these scores were summed and the total score was determined between 0 (poor) and 12 (very good).
Study NCT06400134 — intervention group
Intervention type: OTHER
Intervention: Grip Strength
Description: Muscle strength was assessed with a hand grip dynamometer. In the geriatric individuals, less than 30 kg for men and less than 20 kg for women was considered as low hand grip strength.